Nanoform: Starmap v2.0 AI-based discovery platform
Starmap v2.0 is the latest iteration of Nanoform’s artificial intelligence-based platform. The technology uses sparse-data AI to supplement experimental results from the firm’s CESS platorm, technology that reportedly can produce pure, homogeneous drug particles from solution in an excipient-free process.
Christian Jones, Nanoform’s chief commercial officer, said, “By determining which drug candidates are ideal for our CESS process, the next-gen Starmap platform can potentially create new opportunities for our pharma partners. These can include both revisiting drug candidates unnecessarily discarded by AIs trained on old particle engineering techniques, and rapidly picking winners among new drug candidates.”
